NHS SCOTLAND
Providing advice about the status of all newly licensed medicines
| Drug Number: | 612/10 |
| Drug Name: | rupatadine (Rupafin) |
| Drug Manufacturer: | GlaxoSmithKline |
| BNF Category: | Respiratory system |
| Submission type : | Non submission |
| Date Advice Issued: | 08.03.10 |
| Indication: | Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and adolescents (over 12 years of age). |
There is currently no other SMC advice for this product